Swiss Multicenter Ab Interno XEN45 Gel Stent Study: 2-Year Real-World Data.

Publication

Swiss Multicenter Ab Interno XEN45 Gel Stent Study: 2-Year Real-World Data.

Journal Paper/Review - Apr 6, 2024

Papazoglou Anthia, Höhn René, Schawkat Megir, Tappeiner Christoph, Iliev Milko, Gugleta Konstantin, Saletta Giulia, Wiencierz Andrea, Wagels Barbara, Todorova Margarita, Krzyzanowska Iwona, Töteberg-Harms Marc, Tschopp Markus

Citation

Papazoglou A, Höhn R, Schawkat M, Tappeiner C, Iliev M, Gugleta K, Saletta G, Wiencierz A, Wagels B, Todorova M, Krzyzanowska I, Töteberg-Harms M, Tschopp M. Swiss Multicenter Ab Interno XEN45 Gel Stent Study: 2-Year Real-World Data. Ophthalmol Ther 2024; 13:1513-1525.

Type

Journal Paper/Review (English)

Journal

Ophthalmol Ther 2024; 13

Publication Date

Apr 6, 2024

Issn Print

2193-8245

Pages

1513-1525

Brief description/objective

The aim of this study was to investigate the 2-year postoperative efficacy of the XEN45 Gel Stent by evaluating the reduction of intraocular pressure (IOP) and the need for eye pressure-lowering medications in a multicenter setting in Switzerland.